ATOSNasdaqPharmaceutical PreparationsFiscal year ends December 31
ATOSSA THERAPEUTICS, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026
$2.56−0.35 (-12.03%)
Close on Oct 19, 2026
- Market cap
- $22.81M
- P/E (TTM)
- –
- Dividend yield
- –
Price history
Daily open, high, low, close and volume
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Daily prices are not in StockData yet. This table fills in once an end-of-day price source is connected. | ||||||
Stock splits
From SEC filings
| Date | Ratio | Effect on per-share figures |
|---|---|---|
| Feb 2, 2026 | 1-for-15 reverse | Earlier per-share figures multiplied by 15 |
| Feb 2, 2026 | 1-for-15 reverse | Earlier per-share figures multiplied by 15 |
| May 14, 2018(first seen in filings) | 1-for-12 reverse | Earlier per-share figures multiplied by 12 |
| Apr 20, 2018 | 1-for-12 reverse | Earlier per-share figures multiplied by 12 |
| Nov 14, 2016(first seen in filings) | 1-for-15 reverse | Earlier per-share figures multiplied by 15 |
| Aug 26, 2016 | 1-for-15 reverse | Earlier per-share figures multiplied by 15 |